MYOS Reports Positive Results From Fortetropin(R) Clinical Study
CEDAR KNOLLS, NJ -- (Marketwired) -- 04/22/16 -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of …